Non Muscle Invasive Bladder Cancer (Superficial Bladder Cancer) - Pipeline Review, H2 2016; New Report Launched
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline therapeutics constitutes close to 30 molecules. Out of which approximately 27 molecules are developed by Companies and remaining by the Universities/Institutes. Global Markets Direct's latest report Non Muscle Invasive Bladder Cancer – Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration...
View full press release